CEO Barry Richard Buys $278K More Filana Stock at $0.90-$0.92
FLNA sits 48% above its 52-week low of $0.67 on light trading volume (0.4× avg).
Summary
CEO Barry Richard bought $278,132 of Filana stock at $0.90-$0.92 per share on September 29-30, 2026, adding to a $78,196 purchase made days earlier.
Key Events · Ownership and Investor Activity · FLNA
-
CEO Buys $278K in Open Market
Barry Richard acquired 306,813 shares for $278,132 at $0.90-$0.92 per share on September 29-30, 2026, held via trust.
-
Follows $78K Purchase Days Earlier
This adds to a $78,196 purchase disclosed on September 30, 2026, bringing total recent CEO buying to over $356,000.
-
Post-Transaction Holdings
Richard now holds 1,337,964 shares indirectly through a trust.
-
Nasdaq Minimum-Bid Context
The purchases come after Nasdaq notified Filana on September 17, 2026 that its stock traded below $1.00 for 30 consecutive days.
Analysis · FLNA · Life Sciences
CEO Barry Richard added $278,132 of Filana stock across two open-market purchases on September 29-30, paying $0.90-$0.92 per share. This follows a $78,196 purchase disclosed just days earlier, bringing his total recent buying to over $356,000. The purchases come as the stock trades near $1.00 and the company faces a Nasdaq minimum-bid deficiency notice, making the CEO's continued accumulation a notable vote of confidence in the company's outlook.
How filings like this one have moved
In the 30 days to Oct 19, 2026, 37.9% of the 895 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.87%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, FLNA was trading at $1.00 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $42.8M. The 52-week trading range was $0.67 to $4.98. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.